Workflow
Thenewswire
icon
Search documents
Eastfield Resources Announces Private Placement
Thenewswire· 2025-08-25 13:00
Core Viewpoint - Eastfield Resources Ltd. plans to raise up to $1,000,000 through a non-brokered private placement of up to 50 million units priced at $0.02 per unit, with each unit consisting of one common share and one share purchase warrant [1][2] Group 1 - The placement will be non-brokered, but the company may pay finder's fees in accordance with TSX Venture Exchange rules [2] - The proceeds from the placement will be used for an exploration program at mineral projects in British Columbia and for general working capital, including payments to non-arm's length parties for administrative services and investor relations activities, not exceeding 10% of the proceeds [3] - The securities issued will be subject to a hold period of four months and one day from the date of issuance as per Canadian securities laws [4] Group 2 - Certain insiders of the company may participate in the placement, with details to be included in a future news release [3] - The securities will not be registered under the U.S. Securities Act and cannot be offered or sold in the United States without proper registration or exemption [5]
Quantum Expands Victory Antimony Property in Haida Gwaii, BC
Thenewswire· 2025-08-25 13:00
Core Viewpoint - Quantum Critical Metals Corp. has submitted an application to expand the Victory Antimony Property to 1,444 hectares, emphasizing its commitment to responsible exploration and securing domestic supply chains for critical minerals [1][5]. Company Overview - Quantum Critical Metals Corp. is a Canadian mineral exploration company focused on advancing critical metals projects, including the Victory Antimony Project in British Columbia and others in Québec [16]. Victory Antimony Project Details - The Victory Antimony project was initially discovered in 1988, with historical samples showing significant mineralization, including 11.8% arsenic and 1.24% antimony [3][5]. - The project is characterized as a hydrothermal hot spring deposit type, located within the Middle Jurassic Yakoun group [3]. Expansion Plans - Subject to approval, the company plans to develop access to the expanded property and conduct field programs for verification of historical showings and geological mapping [4]. Importance of Antimony - Antimony is recognized as a critical mineral, primarily used in flame retardants and various technologies, with a global market expected to grow at a CAGR of 5.5% from 2023 to 2030 [8]. - The U.S. Department of Defense has classified antimony as a critical mineral due to its significance in national security [10]. Supply Chain Concerns - China dominates global antimony production, accounting for over 70% of supply, which poses significant risks to industries reliant on this mineral [9]. - Recent geopolitical developments, including China's export bans on antimony, have heightened concerns over supply chain security for critical metals [13][14]. Recent Financial Activity - The company recently closed a private placement, raising $2,009,100.30 in gross proceeds, with associated finders' fees and broker warrants issued [11].
DeepMarkit Provides Corporate Update
Thenewswire· 2025-08-25 13:00
Calgary, Canada – TheNewswire - August 25, 2025 – DeepMarkit Corp. ("DeepMarkit" or the "Company") (TSXV: MKT) (OTC: MKTDF) (FRA: DEP) is pleased to provide a corporate update on its current subsidiaries and the opportunities under evaluation across key technology verticals.DeepMarkit Digital Corp.DeepMarkit Digital is focused on opportunities in the crypto ecosystem, including treasury management strategies, staking and validating activities, prediction markets, and related initiatives that support the de ...
Norsemont Announces Closing of 3rd Tranche of Private Placement Led by Crescat Capital and Equity Management Associates
Thenewswire· 2025-08-25 13:00
Core Viewpoint - Norsemont Mining Inc. has successfully closed the second tranche of a non-brokered private placement, raising CAD $1,191,500.40, with total proceeds from the offering reaching CAD $5,479,199.40, aimed at advancing the Choquelimpie Gold-Silver-Copper project in Northern Chile [1][3][4] Financing Details - The second tranche consisted of 1,985,834 units priced at CAD $0.60 per unit, each unit comprising one common share and one-half of one warrant [1] - Each warrant allows the holder to purchase one common share at CAD $0.75 for two years from the closing date [1] - The offering is subject to a hold period of four months and one day for Canadian investors, with additional restrictions for U.S. investors [2] Use of Proceeds - Proceeds from the offering will fund phase 3 drill programs, including deep drilling into copper porphyry zones and high-grade gold zones, as well as general working capital [3] Project Potential - The Choquelimpie project is described as a massive mineralizing system with significant exploration potential, having previously been a permitted gold and silver mine [5][11] - The project has an initial mineral resource estimate of 2,184,000 indicated gold equivalent ounces and 557,000 inferred gold equivalent ounces [11] - The existing infrastructure includes over 1,700 drill holes, roads, power, water, camp, and a 3,000-tonne-per-day mill, which supports further development [11] Strategic Support - Crescat Capital's involvement and the backing from notable investors like Larry Lepard and Rob McEwen are seen as strong endorsements for the project's potential [4][6] - The management team is focused on responsible and sustainable resource development, leveraging modern exploration techniques to enhance shareholder value [11]
Terra Clean Energy Corp. Engages ICP Securities Inc. for Automated Market Making Services
Thenewswire· 2025-08-25 11:30
Core Viewpoint - Terra Clean Energy Corp has engaged ICP Securities Inc. for automated market making services to enhance liquidity and manage share supply and demand [1][2]. Group 1: Company Overview - Terra Clean Energy Corp, formerly known as Tisdale Clean Energy Corp, is a Canadian uranium exploration and development company [5]. - The company is developing the South Falcon East uranium project, which has an inferred uranium resource of 6.96 million pounds located in the Fraser Lakes B Uranium Deposit in Saskatchewan, Canada [5]. Group 2: Market Making Agreement - The agreement with ICP Securities Inc. includes a monthly fee of C$7,500 for a term of four months, automatically renewing for additional one-month terms unless terminated with a 30-day notice [1]. - ICP will be responsible for its own costs in buying and selling the company's shares, and no third-party funding will be involved in the market-making activities [2]. Group 3: ICP Securities Inc. Profile - ICP Securities Inc. is a Toronto-based CIRO dealer-member specializing in automated market making and liquidity provision, established in 2023 [4]. - The company utilizes its proprietary algorithm, ICP Premium™, to enhance liquidity and quote health for public issuers and institutional investors [4].
Voyageur Pharmaceuticals Launches U.S. Iodine Feasibility Study to Establish First Fully Integrated North American Contrast Drug Manufacturing Platform
Thenewswire· 2025-08-25 11:00
Core Viewpoint - Voyageur Pharmaceuticals Ltd. is launching a U.S.-based iodine feasibility program aimed at establishing a vertically integrated production system for iodine-based contrast media drugs used in diagnostic imaging [1][3]. Group 1: Iodine Feasibility Program - The program will start with bench-scale testing of iodine-rich oilfield brine water to assess the technical and economic viability of iodine extraction [2]. - Voyageur has developed a proprietary manufacturing method called the "Streamline Process," which will be refined during the feasibility phase with third-party engineering experts [2]. - Upon successful testing, the next phase will evaluate the construction of a processing facility for iodine extraction and contrast media drug manufacturing [2]. Group 2: Strategic Goals - The initiative aligns with Voyageur's long-term strategy to vertically integrate the radiology contrast media supply chain from raw mineral extraction to final drug production in North America [3]. - The project addresses national security concerns regarding foreign reliance on the iodine supply chain, currently dominated by manufacturers in Europe and China [3]. - Voyageur aims to capture market share by providing a fully domestic, cost-efficient, and stable supply chain for iodine contrast media [4]. Group 3: Market Demand and Production Plans - According to WHO, there is a significant demand for IV iodinated contrast media, with 3.6 billion diagnostic exams conducted annually, including 350 million on children under 15 [4]. - Global demand for iodinated contrast media is expected to double in the next 10 years, highlighting the need for increased production capacity [4]. - Voyageur plans to scale iodine production to potentially 1,000 tonnes per year for long-term market supply [6]. Group 4: Government Engagement and Partnerships - Voyageur is engaging with U.S. government funding programs for critical minerals and domestic pharmaceutical manufacturing [5]. - The company is in discussions with global iodine contrast media companies and financial groups to support this initiative [5]. Group 5: Business Model and Market Position - Voyageur aims to become a key player in the barium and iodine contrast markets by producing its own active pharmaceutical ingredients (APIs) [7]. - The company plans to partner with established third-party GMP pharmaceutical manufacturers to validate its products by regulatory agencies worldwide [8]. - Voyageur owns a 100% interest in the Frances Creek barium sulphate project, which is expected to produce higher quality imaging products compared to current synthetic alternatives [9]. Group 6: Vision and Commitment - Voyageur's vision is to be the first vertically integrated company in the radiology contrast media drug market, controlling all primary input costs from raw material sourcing to final production [10]. - The company emphasizes responsible sourcing and manufacturing practices, encapsulated in its motto "From the Earth to the Bottle" [10].
Electrum Discovery Updates Shareholders on Operations, Strategy, and Grants Options
Thenewswire· 2025-08-25 06:00
Core Insights - Electrum Discovery Corp. is shifting its focus towards advancing its gold-silver portfolio, particularly the Novo Tlamino project, while maintaining its commitment to copper exploration at the Timok East project [2][4][6] Group 1: Key Assets and Positioning - Electrum fully owns two projects: Timok East (copper-gold) and Novo Tlamino (gold-silver), both located in the Western Tethyan Belt in Serbia [1][26] - The Novo Tlamino project hosts the Barje gold-silver deposit with an inferred resource of 7.1 million tonnes grading 2.5 g/t Au and 38 g/t Ag, equating to approximately 670,000 ounces of AuEq [5][10] Group 2: Strategic Focus and Exploration Plans - The company plans to conduct approximately 3,200 meters of infill drilling and 1,000 meters of step-out drilling at the Barje deposit to support a resource update and test potential extensions [6][12] - Upcoming geophysical surveys at Timok East will refine high-priority drill targets, while the company continues systematic exploration [4][18] Group 3: Market Conditions and Growth Potential - With the strengthening of precious metals markets, the company believes advancing its gold-silver portfolio will yield more immediate returns for shareholders [2][4] - The Barje deposit's mineralization is suitable for conventional open-pit mining, and previous drilling has shown high-grade gold intercepts [6][7][8] Group 4: Future Catalysts - Near-term catalysts include the commencement of Barje infill and step-out drilling, additional metallurgical test-work, and a revised mineral resource estimate for Barje [23] - The company is also advancing target exploration across its 400 km² land package in the Novo Tlamino area, focusing on prospects like Karamanica and Jube Jube [14][15] Group 5: Corporate Developments - Electrum has granted 1,000,000 incentive stock options to its new directors, which are exercisable at $0.13 per common share [24]
Goldgroup Announces Revised Terms of Non-Brokered Private Placement
Thenewswire· 2025-08-23 00:25
Core Viewpoint - Goldgroup Mining Inc. has revised the terms of its non-brokered private placement, aiming to raise up to $4,000,000 through the issuance of units consisting of common shares and warrants [1][3]. Group 1: Private Placement Details - The private placement will consist of up to 5,000,000 units at a price of $0.80 per unit, with each unit comprising one common share and one warrant [1]. - Each warrant will allow the purchase of one additional common share at a price of $1.10 for a period of 24 months from issuance [1]. - The private placement is subject to approval from the TSX Venture Exchange, and all securities will be subject to a statutory hold period of four months and one day from closing [2]. Group 2: Strategic Intent and Use of Proceeds - The net proceeds from the private placement will be primarily used for assessing and pursuing acquisition opportunities in the mining sector [3]. - The company is focused on enhancing shareholder value by potentially acquiring operating mines or strategic stakes in other mining companies [3]. - Goldgroup has been conducting due diligence on various mineral projects but has not yet completed any acquisition transactions [3].
Helix Biopharma Corp. Announces Closing of Private Placement, in Preparation for Institutional Investment and NASDAQ Uplisting
Thenewswire· 2025-08-22 22:00
Core Viewpoint - Helix BioPharma Corp. has successfully closed a non-brokered private placement of 2,222,333 common shares at a price of $0.75 per share, raising gross proceeds of $1,666,750, as part of its bridge financing strategy to secure larger institutional investments [1][2]. Group 1: Private Placement Details - The recent private placement follows a previous one of $3,000,000 announced on January 9, 2025, marking the second phase in Helix's financing strategy [2]. - The net proceeds from this private placement will be allocated towards near-term development activities and working capital [2]. - The offering is subject to final approval from the Toronto Stock Exchange, with a hold period of four months and one day expiring on December 23, 2025 [2]. Group 2: Company Overview - Helix BioPharma is focused on developing innovative solutions for hard-to-treat cancers, with its pipeline led by Tumor Defense Breaker™ L-DOS47, which is designed to enhance the effectiveness of existing cancer therapies [5]. - L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its foundation with Helix's next-generation bi-specific antibody-drug conjugates currently in discovery [5]. - The company is also advancing two pre-IND candidates: LEUMUNA™, an oral immune checkpoint modulator, and GEMCEDA™, a first-in-class oral gemcitabine prodrug [5].
Bitcoin Well Reports 2025 Q2 Financial Results
Thenewswire· 2025-08-22 11:30
Edmonton, Alberta – August 22, 2025 – TheNewswire - Bitcoin Well Inc. (“Bitcoin Well” or the “Company”) (TSXV: BTCW; OTCQB: BCNWF), the non-custodial bitcoin business on a mission to enable independence, today announced financial and operating results for the second quarter ended June 30, 2025.Key highlights Revenue of $32.1 million for the 3-months ended June 30, 2025 (Q2 2024: $23.3 million, +38%) and $63.9 million for the 6-months ended June 30, 2025 (2024: $39.4 million, +62%).  Online Bitcoin Portal ...